Lastest from Businesswire

CORAL GABLES, Fla.--(BUSINESS WIRE)--Pibank, the direct banking solution of Intercredit Bank, has formally launched its U.S. presence with a 5.50% APY high-yield savings account. The direct bank, which already has a robust presence in Spain and Colombia, will now be offering its high-yield, customer-centric savings products to U.S. consumers. Pibank’s success stems from its high-yield savings offerings with no fees, no minimum balance, and they are FDIC-Insured. Pibank’s key differential advant

BOSTON--(BUSINESS WIRE)--State Street Corporation (NYSE: STT) announced today that Joerg Ambrosius, executive vice president and chief commercial officer, has been appointed president of Investment Services, State Street’s largest business. Ambrosius brings more than 30 years of financial services experience, with a successful track record of leading client management, sales and revenue growth, focusing on the needs of asset managers and institutional investors. Ambrosius assumed an expanded rol

CHICAGO--(BUSINESS WIRE)--FHLBank Chicago opens application for the 2024 Community First® Diverse Developer Initiative making available $2 million to qualifying organizations.

CHICAGO--(BUSINESS WIRE)--Alight completes cloud migration transformation, delivering enhanced performance and significant cost savings

NEW HAVEN, Conn.--(BUSINESS WIRE)--Halda Therapeutics, a biotechnology company developing a novel class of cancer therapies called RIPTACTM (Regulated Induced Proximity TArgeting Chimeras) therapeutics, today announced that it has raised new financing of $126 million in a Series B extension, including funding from new investors Deep Track Capital, Frazier Life Sciences, RA Capital Management, Vida Ventures, Boxer Capital and Taiho Ventures, as well as existing investors Canaan Partners, Access

TORONTO--(BUSINESS WIRE)--Dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL), Canada’s largest and one of North America’s fastest growing networks of dental practices, today announced that it will present at the following investor conferences: Morgan Stanley Annual Global Healthcare Conference – September 4, 2024 Location: New York, NY CIBC Eastern Institutional Investor Conference – September 26, 2024 Location: Montreal, QC Replays of select presentations will be made availab

NEW YORK--(BUSINESS WIRE)--Jefferies Financial Group, Inc. (NYSE: JEF) (“Jefferies”) today announced the appointment of the Sumitomo Mitsui Financial Group, Inc. (NYSE: SMFG) (“SMFG”) President and Group Chief Executive Officer, Toru Nakashima, to Jefferies’ Board of Directors effective August 12, 2024. The appointment of Mr. Nakashima further strengthens the strategic alliance between Jefferies and the SMBC Group first announced in 2021 and then further expanded in 2023 and 2024. Consistent wi

NEW YORK--(BUSINESS WIRE)--Lazard, Inc. (NYSE: LAZ) reported today that its preliminary assets under management (“AUM”) as of July 31, 2024 totaled approximately $246.1 billion. The month’s AUM included net outflows of $3.6 billion, market appreciation of $3.5 billion and foreign exchange appreciation of $1.5 billion. LAZARD, INC. ASSETS UNDER MANAGEMENT ("AUM") (unaudited) ($ in millions)       As of:   July 31, June 30,   20241 2024 Equity   $192,176 $190,426 Fixed Income   45,775 46,111 Othe

LOS ANGELES--(BUSINESS WIRE)--Banc of California, Inc. (the “Company”) (NYSE: BANC) announced today that its Board of Directors declared a quarterly cash dividend of $0.10 per share on its outstanding common stock. The dividend will be payable October 1, 2024, to stockholders of record as of September 16, 2024. The Board of Directors also declared a quarterly cash dividend of $0.4845 per depositary share on its 7.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series F. The dividend wi

LAS VEGAS--(BUSINESS WIRE)---- $AGREE #AGREE--Ault Alliance Announces that Sentinum, its Wholly Owned Subsidiary, Has Mined 552 Bitcoin in 2024 and 2,894 Bitcoin Since Inception

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Ford business and prospects, resulting in its stock trading at inflated prices.

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning lululemon business and prospects, resulting in its stock trading at inflated prices.

CHATHAM, N.J.--(BUSINESS WIRE)--Chatham Asset Management, LLC (“Chatham”), a private investment firm and the largest creditor of Mohegan Tribal Gaming Authority (“MOHEGN” or the “Company”), today issued the following statement regarding the Company’s 8.000% Second Priority Senior Secured Notes due February 1, 2026 (the “2026 Notes”) and 13.250% Senior Notes due December 15, 2027 (the “2027 Notes”): “MOHEGN continues to perform well, highlighted by strong financial results in the recently report

MIAMI--(BUSINESS WIRE)--Tigertail Capital Partners (“TCP”), a Miami-based investment firm, is pleased to announce its official launch. TCP is dedicated to investing in founder-owned businesses across highly fragmented industries with limited tech-enablement to-date. TCP is led by Alex Gatof, Andrew Och and Zach Katz, who collectively have over 25 years of experience in private and public market investing in addition to software and data engineering. Tigertail Capital Partners will be focused on

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Blue Owl Capital Corporation III (“OBDE” or the “Company”) (NYSE: OBDE) and Blue Owl Capital Corporation (NYSE: OBDC). Under the terms of the proposed transaction, shareholders of OBDE will receive newly issued shares of OBDC for each share of OBDE based on an exchange ratio determined prior to closing. KSF

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of GSE Systems, Inc. (NasdaqCM: GVP) to Pelican Energy Partners. Under the terms of the proposed transaction, shareholders of GSE will receive $4.10 in cash for each share of GSE that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consi

NEW YORK--(BUSINESS WIRE)---- $LPLA #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of LPL Financial Holdings Inc. (“LPL” or “the Company”) (NASDAQ: LPLA). Investors who purchased LPL securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/LPLA. Investigation Details LPL is the subject of a temporary restraining order issued by a federal judge on behalf of Amerip

NEW YORK--(BUSINESS WIRE)---- $INDV #classaction--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Indivior PLC (“Indivior” or “the Company”) (NASDAQ: INDV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Indivior securi

NEW YORK--(BUSINESS WIRE)---- $FNA #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. (“Paragon 28” or “the Company”) (NYSE: FNA). Investors who purchased Paragon 28 securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FNA. Investigation Details On July 30, 2024, Paragon 28 filed a current report on Form 8-K with the SEC, and stated that “On

NEW YORK--(BUSINESS WIRE)---- $PEPG #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PepGen Inc. (“PepGen” or “the Company”) (NASDAQ: PEPG). Investors who purchased PepGen securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/PEPG. Investigation Details PepGen released data from its ongoing Phase 2 trial of its drug candidate PGN-EDO51 on July 30, 2024. Follo